Astellas Pharma (Germany) Analysis

Astellas Stock Analysis Notes

About 50.0% of the company outstanding shares are owned by institutional investors. The book value of Astellas Pharma was at this time reported as 847.56. The company last dividend was issued on the 30th of March 2023. Astellas Pharma had 5:1 split on the 27th of March 2014. Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. Astellas Pharma Inc. was founded in 1923 and is headquartered in Tokyo, Japan. ASTELLAS PHARMA operates under Drug ManufacturersGeneral classification in Germany and is traded on Frankfurt Stock Exchange. It employs 15455 people. For more information please call Kenji Yasukawa at 81 3 3244 3000 or visit https://www.astellas.com.

Astellas Pharma Investment Alerts

Astellas Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 23.71 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Astellas Pharma's market, we take the total number of its shares issued and multiply it by Astellas Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Astellas Profitablity

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17.

Technical Drivers

As of the 4th of December, Astellas Pharma shows the Standard Deviation of 2.19, risk adjusted performance of (0.03), and Mean Deviation of 1.62. In respect to fundamental indicators, the technical analysis model gives you tools to check existing technical drivers of Astellas Pharma, as well as the relationship between them. Please confirm Astellas Pharma information ratio, potential upside, and the relationship between the standard deviation and maximum drawdown to decide if Astellas Pharma is priced correctly, providing market reflects its regular price of 10.02 per share.

Astellas Pharma Price Movement Analysis

Astellas Pharma Outstanding Bonds

Astellas Pharma Predictive Daily Indicators

Astellas Pharma Forecast Models

Astellas Pharma's time-series forecasting models are one of many Astellas Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Astellas Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Astellas Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Astellas shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Astellas Pharma. By using and applying Astellas Stock analysis, traders can create a robust methodology for identifying Astellas entry and exit points for their positions.

When running Astellas Pharma's price analysis, check to measure Astellas Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astellas Pharma is operating at the current time. Most of Astellas Pharma's value examination focuses on studying past and present price action to predict the probability of Astellas Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astellas Pharma's price. Additionally, you may evaluate how the addition of Astellas Pharma to your portfolios can decrease your overall portfolio volatility.